Methyltetrazine-DBCO is a heterobifunctional ADC linker enabling fast, selective dual click chemistry reactions (IEDDA and SPAAC), enhancing conjugation efficiency in antibody-drug conjugate production.
Structure of 1802238-48-7
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Methyltetrazine-DBCO, a versatile chemical compound utilized in bioorthogonal chemistry for labeling and conjugation, offers a plethora of applications.
Bioconjugation Techniques: Leveraging Methyltetrazine-DBCO, scientists can achieve site-specific biomolecule conjugation through the rapid tetrazine ligation—a bioorthogonal reaction that ensures precise labeling of proteins, nucleic acids, or small molecules without disrupting biological systems. This technique is invaluable for creating bioconjugates tailored for diagnostic and therapeutic uses.
Live-Cell Imaging: Methyltetrazine-DBCO's exceptional characteristics make it an indispensable tool for live-cell imaging endeavors. By fluorescently tagging live cells using the tetrazine ligation, researchers can dynamically visualize cellular processes in real time, enhancing the study of biological events without perturbing normal cellular functions.
In Vivo Tracking: The utilization of Methyltetrazine-DBCO for in vivo biomolecule tracking in animal models is paramount. Through conjugation with imaging agents, scientists can monitor the distribution and accumulation of labeled molecules within live organisms, offering insights into biodistribution, pharmacokinetics, and the efficacy of drug candidates—an essential aspect of drug development.
Targeted Drug Delivery: Methyltetrazine-DBCO plays a pivotal role in enabling targeted drug delivery by selectively conjugating therapeutic agents to carrier molecules or targeting moieties. This approach enhances the precise delivery of drugs to diseased tissues or cells, mitigating off-target effects and optimizing therapeutic outcomes. Such innovative strategies are instrumental in designing sophisticated drug delivery systems for combating diseases like cancer.
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-01542 | Methyltetrazine-PEG5-nhs ester | 1802907-92-1 | |
BADC-01962 | Methyltetrazine-amino-PEG4-amine | 2055646-21-2 | |
BADC-01959 | Methyltetrazine-amino-PEG3-CH2CH2NHBoc | 2141976-32-9 | |
BADC-01960 | Methyltetrazine-amino-PEG4-CH2CH2NHBoc | 2143955-71-7 | |
BADC-01958 | Methyltetrazine-amino-PEG8-CH2CH2NHMal | 2143968-05-0 | |
BADC-01961 | Methyltetrazine-amino-PEG8-CH2CH2NHBoc | 2143968-21-0 | |
BADC-01709 | Methyltetrazine-amido-N-bis(PEG4-acid) | 2639395-39-2 | |
BADC-01890 | Methyltetrazine-PEG12-acid | ||
BADC-01293 | Methyltetrazine-SS-PEG4-Biotin | ||
BADC-01885 | Methyltetrazine-PEG12-NHS ester |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.